sglt2 glp 1 combination THERAPY WITH GLP-1 RECEPTOR AGONIST AND INHIBITOR A retrospective analysis of combination

The company's total production volume has more than doubled over the past three years

Stratification of obesity phenotypes to optimize future therapy (SOPHIA) Expert

In addition, BBR treatment increase the expression of enzymes involved in phospholipid and fatty acid uptake in the heart, which has a strong protective effect against cardiac dysfunction in gestational diabetic mice (Cole et al., 2021a

Glycemic improvement with a fixed-dose combination of DPP-4 inhibitor + metformin in patients with type 2 diabetes (GIFT study)

Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice